Aberdare Ventures

Aberdare Ventures is a San Francisco-based venture capital firm founded in 1999 and focused exclusively on transformational healthcare companies. Led by Managing Partner Paul Klingenstein and a three-partner team, the firm has built a portfolio of 101 investments spanning seed through later stage, making it one of the most active and longest-tenured healthcare-focused VCs in the United States. Aberdare also deploys private equity and grants capital to the healthcare sector, reflecting a broad commitment to the ecosystem rather than a narrow venture mandate. The firm invests $1 million to $15 million per round in companies that apply biological, engineering, and information technologies to make healthcare more efficient, less costly, and smarter. The portfolio skews heavily toward health technology and biotech, with 55 and 20 investments respectively, supplemented by software and data analytics companies that serve the healthcare industry. Aberdare leads rounds across its investment spectrum. Aberdare Ventures' quarter-century of healthcare specialization has produced deep pattern recognition in a sector where regulatory complexity, long development timelines, and reimbursement dynamics make generalist investors less equipped to evaluate risk. The firm's longevity and focused mandate allow it to bring experienced judgment to founders navigating the clinical development, FDA approval, and commercialization processes that define success in medical technology. Its extensive portfolio and active board involvement provide portfolio companies with a network of peers, advisors, and potential partners across the healthcare landscape.